Moreover, plasma CS/DS and HS/H levels were significantly higher in female RA patients before anti-TNF-α therapy in comparison to healthy subjects (p <0.01 and p <0.001, respectively; Table 2). This evidence concerns the gene TNF and rheumatoid arthritis.